8/2/2010

The FDA has decided to reopen the period for accepting public feedback on a proposal to reclassify certain types of neurological and physical medicine devices from Class III, or high-risk, to Class II, or medium-risk. The agency has set a Sept. 7 deadline for public comments.

Related Summaries